Claudia Cosgrove

Claudia Cosgrove

Auto-generated profile, based on publicly available information

Claudia Cosgrove

City St George's University of London London UK

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in EuroIntervention
Verified
Journal Article
Closed access
SWSimon J Wilson
Simon J Wilson
JSJames C Spratt
James C Spratt
JHJonathan Hill
Jonathan Hill
MSMark S Spence
Mark S Spence
CCClaudia Cosgrove
Claudia Cosgrove
CHColm G Hanratty
Colm G Hanratty
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

1 May 2020 in EuroIntervention
Verified
Journal Article
Closed access
CCClaudia S Cosgrove
Claudia S Cosgrove
SWSimon J Wilson
Simon J Wilson
RBRichard Bogle
Richard Bogle
CHColm G Hanratty
Colm G Hanratty
RWRupert Williams
Rupert Williams
JSJames C Spratt
James C Spratt
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

8 January 2020 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
JYJulian Yeoh
Julian Yeoh
DCDaan Cottens
Daan Cottens
CCClaudia Cosgrove
Claudia Cosgrove
KMKhaled Mallek
Khaled Mallek
JSJulian Strange
Julian Strange
JSJames Spratt
James Spratt

21 June 2021 in Journal of Interventional Cardiology
Verified
Journal Article
Open access
PDF file
AØAnja Øksnes
Anja Øksnes
CCClaudia Cosgrove
Claudia Cosgrove
SWSimon Walsh
Simon Walsh
KLKjetil Halvorsen Løland
Kjetil Halvorsen Løland
JLJack Laffan
Jack Laffan
MMMargaret McEntegart
Margaret McEntegart
Intravascular lithotripsy (IVL) has been shown to be safe and effective for calcium modification in nonocclusive coronary artery disease (CAD), but there are only case reports of its use in calcified chronic total occlusions (CTO). We report data from an international multicenter registry of IVL use during CTO percutaneous coronary intervention (PCI) and provide provisional data regarding its efficacy and safety. During the study period, IVL was used in 55 of 1053 (5.2%) CTO PCI procedures. IVL was used within the occluded segment after successful CTO crossing in 53 procedures and during incomplete CTO crossing in 2 cases. The mean J-CTO score was 3.1. CTO PCI technical and procedural success was achieved in 53 (96%) and 51 (93%) cases. Six patients had a procedural complication, with 3 main vessel perforations (5%). Two had covered stent implantation, one required pericardiocentesis, and one was managed conservatively. All had combination therapy with another calcium modification device. Two patients had a procedural myocardial infarction (PMI) (4%), and two others had a major adverse cardiovascular event (MACE) (4%) at a median follow-up of 13 (4–21) months. IVL can effectively facilitate calcium modification during CTO PCI. More data are required to establish the efficacy and safety of IVL and other calcium modification devices when used extraplaque or in combination during CTO PCI.

12 October 2021 in Interventional Cardiology: Reviews, Research, Resources
Verified
Journal Article
Open access
KMKalaivani Mahadevan
Kalaivani Mahadevan
CCClaudia Cosgrove
Claudia Cosgrove
JSJulian W Strange
Julian W Strange
Stent failure remains one of the greatest challenges for interventional cardiologists. Despite the evolution to superior second- and third-generation drug-eluting stent designs, increasing use of intracoronary imaging and the adoption of more potent antiplatelet regimens, registries continue to demonstrate a prevalence of stent failure or target lesion revascularisation of 15–20%. Predisposition to stent failure is consistent across both chronic total occlusion (CTO) and non-CTO populations and includes patient-, lesion- and procedure-related factors. However, histological and pathophysiological properties specific to CTOs, alongside complex strategies to treat these lesions, may potentially render percutaneous coronary interventions in this cohort more vulnerable to failure. Prevention requires recognition and mitigation of the precipitants of stent failure, optimisation of interventional techniques, including image-guided precision percutaneous coronary intervention, and aggressive modification of a patient’s cardiovascular risk factors. Management of stent failure in the CTO population is technically challenging and itself begets recurrence. We aim to provide a comprehensive review of factors influencing stent failure in the CTO population and strategies to attenuate these.

20 October 2021 in Interventional Cardiology: Reviews, Research, Resources
Verified
Journal Article
Open access
CCClaudia Cosgrove
Claudia Cosgrove
KMKalaivani Mahadevan
Kalaivani Mahadevan
JSJames Spratt
James Spratt
MMMargaret McEntegart
Margaret McEntegart
Coronary artery calcification is prevalent in chronic total occlusions (CTO), particularly in those of longer duration and post-coronary artery bypass. The presence of calcium predicts lower procedural success rates and a higher risk of complications of CTO percutaneous coronary intervention. Adjunctive imaging, including pre-procedural computed tomography and intracoronary imaging, are useful to understand the distribution and morphology of the calcium. Specialised guidewires and microcatheters, as well as penetration, subintimal entry and luminal re-entry techniques, are required to cross calcific CTOs. The use of both atherectomy devices and balloon-based calcium modification tools has been reported during CTO percutaneous coronary intervention, although they are limited by concerns regarding safety and efficacy in the subintimal space.